You are trying to discuss with a poster who thinks himself far more intelligent than all (on CYP or MSB) who just finally worked out that Cynata has pretty much been cash flow negative since its IPO in 2007. Sell it. Its doomed. But wasn't in the 17 years prior until now!
What's funny he is now in agreement with a long term CYP antagonist who has shown himself to repeatedly mis-read cash flow statements, forget R&D rebates, etc, in the continuous FUD he tries to throw at CYP's cash burn (as if investors unaware) and indeed shows similar misunderstanding of the subject with respect to his favoured holding, MSB, on threads therein.
- Forums
- ASX - By Stock
- CYP
- CYP Price Target post MSB FDA approval.
CYP
cynata therapeutics limited
Add to My Watchlist
6.25%
!
17.0¢

CYP Price Target post MSB FDA approval., page-14
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
17.0¢ |
Change
0.010(6.25%) |
Mkt cap ! $39.54M |
Open | High | Low | Value | Volume |
16.0¢ | 17.5¢ | 16.0¢ | $42.36K | 259.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 19056 | 17.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.5¢ | 68496 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 19056 | 0.170 |
2 | 30655 | 0.165 |
4 | 645374 | 0.160 |
4 | 66451 | 0.155 |
2 | 55000 | 0.150 |
Price($) | Vol. | No. |
---|---|---|
0.175 | 68496 | 3 |
0.180 | 118274 | 7 |
0.185 | 58190 | 2 |
0.190 | 8868 | 1 |
0.195 | 28488 | 3 |
Last trade - 13.32pm 18/06/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online